Showing results (31-40 of 72) with videos related to
Sort By:
Pageof 8
International Journal of Cancer|December 4, 2010
Bystander effect of vinorelbine alters antitumor immune responseAudrey Thomas-Schoemann, François Lemare, Céline Mongaret, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2012
Arsenic trioxide exerts antitumor activity through regulatory T cell depletion mediated by oxidative stress in a murine model of colon cancerAudrey Thomas-Schoemann, Frédéric Batteux, Céline Mongaret, et al.International Journal of Environmental Research and Public Health|March 11, 2023
Experiences of Inter-Hospital Transfers (IHT) by Patients and Relatives during the COVID-19 Pandemic in France: A Qualitative StudyNicolas Chauliac, Germain Salome, Juliette Cheucle, et al.Pharmacological Research|July 6, 2016
Plasma vemurafenib exposure and pre-treatment hepatocyte growth factor level are two factors contributing to the early peripheral lymphocytes depletion in BRAF-mutated melanoma patientsAlicja Puszkiel, Mélanie White-Koning, Nicolas Dupin, et al.Targeted Oncology|May 21, 2017
Circulating Tumor DNA Measurement by Picoliter Droplet-Based Digital PCR and Vemurafenib Plasma Concentrations in Patients with Advanced BRAF-Mutated MelanomaFanny Garlan, Benoit Blanchet, Nora Kramkimel, et al.Cancer Chemotherapy and Pharmacology|August 24, 2023
Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resectionCléa Tardy, Alicja Puszkiel, Pascaline Boudou-Rouquette, et al.JAMA Network Open|February 24, 2026
Sleep Apnea-Specific Hypoxic Burden and Postoperative Outcomes of Major Noncardiothoracic SurgerySébastien Bailly, Abdelkebir Sabil, Margaux Blanchard, et al.British Journal of Clinical Pharmacology|January 29, 2023
Cardiac toxicity associated with pharmacokinetic drug-drug interaction between crizotinib and sofosbuvir/velpatasvir: A case reportAnthia Monribot, Olivier Huillard, Nihel Khoudour, et al.Investigational New Drugs|November 1, 2016
Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-oldFrederic Bigot, Pascaline Boudou-Rouquette, Jennifer Arrondeau, et al.Clinical Therapeutics|April 21, 2019
Pharmacokinetics and Pharmacodynamics of Once-daily Prolonged-release Tacrolimus in Liver Transplant RecipientsMarie Allard, Alicja Puszkiel, Filomena Conti, et al.Pageof 8